Lupin manufacture Merck Serono’s drugs worth $1.5 billion

Lupin to manufacture Merck Serono’s drugs worth $1.5 billion

11:54 AM, 16th September 2014
Lupin to manufacture Merck Serono’s drugs worth $1.5 billion

MUMBAI, INDIA: Pharmaceutical major Lupin is in advanced talks to sign a deal with Merck Serono. As part of the deal, Lupin will manufacture Merck Serono’s $1.5 billion worth branded mature drugs at its facilities. The company will also get marketing rights for the drugs for emerging countries and European markets. Merck Serono will retain the rights to market these drugs in the developed markets.

“The branded drugs segment with sales close to $1.5 billion will have an EBITDA close to $900 million. Assuming 30 per cent margins; Lupin would make close to Rs 1500 crore ($245.40 million) on an operational level on this deal,” said an analyst.

© The Economic Times News  




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

BASF, Cargill, Novozymes reach new milestone in bio acrylic acid production

LUDWIGSHAFEN, GERMANY/MINNEAPOLIS, US/COPENHAGEN, DENMARK: BASF, Cargill and Novozymes announced the achievement of another milestone in their joint d ...

Read more
BASF to expand solvent extractants production capacity in Ireland

LUDWIGSHAFEN, GERMANY/CORK, IRELAND: BASF will expand the manufacturing plant for its LIX product range at its Cork site, Ireland. An investment is un ...

Read more
Advanced petrochemical approves equity investment in PDH plant with SK gas in South Korea

JUBAIL, SAUDI ARABIA: Advanced Petrochemical Company approved the equity investment of 35 per cent in propane dehydrogenation (PDH) Plant with SK Gas, ...

Read more
New method to produce hydrogen 30 times faster

GLASGOW, SCOTLAND: Researchers at University of Glasgow have reported a new method of producing hydrogen that’s 30 times faster than current sta ...

Read more
Sabic signs research agreement with Chinese Academy of Sciences

BEIJING, CHINA: To propel the progress of science and technology in China, Sabic and the Chinese Academy of Sciences (CAS), a public research and educ ...

Read more
Cargill files lawsuit against Syngenta

RESERVE, US: Cargill filed a lawsuit against Syngenta Seeds, Inc in Louisiana state court, seeking damages from Syngenta for commercializing its Agris ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X